Biomebank Is A Clinical Stage Biotechnology Company Dedicated To Developing Microbiome Based Therapies To Restore Health By Treating The Gut Microbial Ecosystemfounded In 2018 By A Team Of Expertsthe Company Has Made Significant Strides In Microbiome Research And Therapy Development Biomebank Offers Innovative Services And Productsincluding The World S First Approved Biotherapeutic For Recurrent And Refractoryclostridioides Difficileinfectionderived From Donor Microbiotatheir Consortiome Tm Platform Enables The Production Of Complex Synthetic Bacterial Communitiesallowing For Scalable And Cost Effective Manufacturingadditionallybiomebank Is Advancing Second Generation Cultured Therapies From A Diverse Collection Of Over 35 000 Bacteriatargeting Diseases Like Ulcerative Colitis And Crohnae S Disease The Company Collaborates With Leading Biomedical Research Organizations And Hospitalsincluding Rmit University And St Vincentae S Hospitalto Support The Development Of Microbiome Therapiesoperating From A State Of The Art Cgmp Manufacturing Facility In Adelaidebiomebank Is Poised For Continued Growth And Innovation In The Field Of Microbiome Health
